Nicosia, Cyprus. The Cyprus Institute of Neurology and Genetics (CING) will host a European conference on rare diseases on June 16-17, 2026, jointly organised with the Deputy Ministry of Research, Innovation and Digital Policy. The event will bring together experts to advance innovative treatments.
Conference framework and focus
The conference, titled “Advancement of Treatments for Rare Diseases,” will be held within the framework of the Cypriot Presidency of the Council of the European Union, highlighting Cyprus’ role in European health policy dialogue.
Expected participation
Organisers said the event is expected to feature more than 40 speakers and around 250 participants from multiple countries, representing healthcare, research, the pharmaceutical industry and patient organisations.
Aims and scope
The initiative aims to strengthen collaboration and innovation in rare diseases, promote scientific research and improve patient access to modern therapies, underscoring the importance of coordinated action across sectors. Organisers added that the breadth and depth of topics position the conference as a significant scientific event for professionals involved in research, clinical practice, policymaking and innovation management in rare diseases.
Institutional representation and exchange
Organisers said participation by senior officials, European Commission representatives, and experts from the European Medicines Agency, alongside European Reference Networks and academics, underscores Cyprus’ role as a hub for scientific dialogue and cooperation in the field. The conference is also expected to serve as a platform for exchanging knowledge, experience and best practices, strengthening links between research, clinical application, regulatory frameworks and health policy.
Registration requirements
Organisers said registration is mandatory for all attendees and must be completed through the official accreditation platform of the Cypriot EU Presidency. Participants must first obtain an individual access code, which can be requested by email, and applicants are required to specify whether they are speakers, local participants or international attendees.
Will you register through the official accreditation platform and request an individual access code by email?